| # | Drug | Count |
|---|---|---|
| 0 | BENRALIZUMAB | 9 |
| 1 | MEPOLIZUMAB | 8 |
| 2 | DUPILUMAB | 7 |
| 3 | PREDNISOLONE | 7 |
| 4 | PREDNISOLONE ORAL | 7 |
| 5 | PREDNISOLONE ORAL SOLUTION | 7 |
| 6 | MONTELUKAST | 5 |
| 7 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 4 |
| 8 | MONTELUKAST SODIUM | 3 |
| 9 | THEOPHYLLINE ANHYDROUS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 1 | BRODALUMAB | 1 | 0.0005 |
| 2 | BENRALIZUMAB | 9 | 0.0004 |
| 3 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 1 | 0.0002 |
| 4 | THEOPHYLLINE ANHYDROUS | 3 | 0.0002 |
| 5 | DEGARELIX | 1 | 0.0002 |
| 6 | OLOPATADINE HYDROCHLORIDE | 1 | 0.0002 |
| 7 | CILOSTAZOL | 1 | 0.0002 |
| 8 | MEPOLIZUMAB | 8 | 0.0002 |
| 9 | APREPITANT | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 9 | 0.0004 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 7 | Methylxanthine [EPC] | 3 | 0.0001 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 9 | Anti-IgE [EPC] | 2 | 0.0000 |